- Home
- HTLD vs AUTL Comparison
HTLD vs AUTL Comparison
Compare HTLD & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTLD
- AUTL
- Stock Information
- Founded
- HTLD 1978
- AUTL 2014
- Country
- HTLD United States
- AUTL United Kingdom
- Employees
- HTLD N/A
- AUTL N/A
- Industry
- HTLD Trucking Freight/Courier Services
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HTLD Industrials
- AUTL Health Care
- Exchange
- HTLD Nasdaq
- AUTL Nasdaq
- Market Cap
- HTLD 622.9M
- AUTL 625.4M
- IPO Year
- HTLD N/A
- AUTL 2018
- Fundamental
- Price
- HTLD $8.49
- AUTL $1.33
- Analyst Decision
- HTLD Hold
- AUTL Strong Buy
- Analyst Count
- HTLD 5
- AUTL 5
- Target Price
- HTLD $9.70
- AUTL $9.12
- AVG Volume (30 Days)
- HTLD 624.9K
- AUTL 4.2M
- Earning Date
- HTLD 10-28-2025
- AUTL 11-11-2025
- Dividend Yield
- HTLD 0.94%
- AUTL N/A
- EPS Growth
- HTLD N/A
- AUTL N/A
- EPS
- HTLD N/A
- AUTL N/A
- Revenue
- HTLD $932,244,000.00
- AUTL $29,934,000.00
- Revenue This Year
- HTLD N/A
- AUTL $634.25
- Revenue Next Year
- HTLD $4.57
- AUTL $93.16
- P/E Ratio
- HTLD N/A
- AUTL N/A
- Revenue Growth
- HTLD N/A
- AUTL 185.17
- 52 Week Low
- HTLD $7.11
- AUTL $1.11
- 52 Week High
- HTLD $12.85
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- HTLD 51.81
- AUTL 27.58
- Support Level
- HTLD N/A
- AUTL $1.30
- Resistance Level
- HTLD $8.81
- AUTL $1.46
- Average True Range (ATR)
- HTLD 0.22
- AUTL 0.09
- MACD
- HTLD -0.32
- AUTL 0.01
- Stochastic Oscillator
- HTLD 96.58
- AUTL 11.59
About HTLD Heartland Express Inc.
Heartland Express Inc is engaged in providing truckload services across the United States, Mexico, and Canada. These truckload services are asset-based transportation services in the dry van truckload market. The company offers truckload temperature-controlled transportation services, and Mexico logistics services. A majority of its customers represent the consumer goods, appliances, food products, and automotive industries.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.